Remdesivir's Real-World impact on severe COVID-19 examined
NCT ID NCT04365725
First seen Jan 18, 2026 · Last updated May 21, 2026 · Updated 17 times
Summary
This study reviewed medical records of 84 hospitalized adults with severe COVID-19 who received remdesivir. Researchers tracked their recovery using a 7-point scale at different time points. The goal was to understand how well the drug worked outside of clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.